Wnt signaling in osteoblasts and bone diseases JJ Westendorf, RA Kahler, TM Schroeder Gene 341, 19-39, 2004 | 1044 | 2004 |
Sarcoma derived from cultured mesenchymal stem cells J Tolar, AJ Nauta, MJ Osborn, A Panoskaltsis Mortari, RT McElmurry, ... Stem cells 25 (2), 371-379, 2007 | 824 | 2007 |
Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate L Pederson, M Ruan, JJ Westendorf, S Khosla, MJ Oursler Proceedings of the National Academy of Sciences 105 (52), 20764-20769, 2008 | 601 | 2008 |
ETO, a target of t (8; 21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors B Lutterbach, JJ Westendorf, B Linggi, A Patten, M Moniwa, JR Davie, ... Molecular and cellular biology 18 (12), 7176-7184, 1998 | 567 | 1998 |
Update on Wnt signaling in bone cell biology and bone disease DG Monroe, ME McGee-Lawrence, MJ Oursler, JJ Westendorf Gene 492 (1), 1-18, 2012 | 490 | 2012 |
Building bone to reverse osteoporosis and repair fractures S Khosla, JJ Westendorf, MJ Oursler The Journal of clinical investigation 118 (2), 421-428, 2008 | 490 | 2008 |
Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21CIP1/WAF1 promoter JJ Westendorf, SK Zaidi, JE Cascino, R Kahler, AJ Van Wijnen, JB Lian, ... Molecular and cellular biology, 2002 | 413 | 2002 |
Runx2: a master organizer of gene transcription in developing and maturing osteoblasts TM Schroeder, ED Jensen, JJ Westendorf Birth Defects Research Part C: Embryo Today: Reviews 75 (3), 213-225, 2005 | 400 | 2005 |
Transplanted senescent cells induce an osteoarthritis-like condition in mice M Xu, EW Bradley, MM Weivoda, SM Hwang, T Pirtskhalava, T Decklever, ... Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2017 | 352 | 2017 |
The t (8; 21) fusion product, AML-1–ETO, associates with C/EBP-α, inhibits C/EBP-α-dependent transcription, and blocks granulocytic differentiation JJ Westendorf, CM Yamamoto, N Lenny, JR Downing, ME Selsted, ... Molecular and cellular biology, 1998 | 323 | 1998 |
Wnt signaling as a therapeutic target for bone diseases LH Hoeppner, FJ Secreto, JJ Westendorf Expert opinion on therapeutic targets 13 (4), 485-496, 2009 | 318 | 2009 |
A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia B Lutterbach, JJ Westendorf, B Linggi, S Isaac, E Seto, SW Hiebert Journal of Biological Chemistry 275 (1), 651-656, 2000 | 305 | 2000 |
Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation TM Schroeder, RA Kahler, X Li, JJ Westendorf Journal of biological Chemistry 279 (40), 41998-42007, 2004 | 289 | 2004 |
Histone deacetylase inhibitors promote osteoblast maturation TM Schroeder, JJ Westendorf Journal of Bone and Mineral Research 20 (12), 2254-2263, 2005 | 288 | 2005 |
Mesenchymal stem cells for bone repair and metabolic bone diseases AH Undale, JJ Westendorf, MJ Yaszemski, S Khosla Mayo clinic proceedings 84 (10), 893-902, 2009 | 286 | 2009 |
Lymphoid Enhancer Factor-1 and ॆ-Catenin Inhibit Runx2-dependent Transcriptional Activation of the Osteocalcin Promoter RA Kahler, JJ Westendorf Journal of Biological Chemistry 278 (14), 11937-11944, 2003 | 281 | 2003 |
Regulation of gene expression in osteoblasts ED Jensen, R Gopalakrishnan, JJ Westendorf Biofactors 36 (1), 25-32, 2010 | 270 | 2010 |
MicroRNA functions in osteogenesis and dysfunctions in osteoporosis AJ Van Wijnen, J Van De Peppel, JP Van Leeuwen, JB Lian, GS Stein, ... Current osteoporosis reports 11, 72-82, 2013 | 246 | 2013 |
The histone H3. 3K36M mutation reprograms the epigenome of chondroblastomas D Fang, H Gan, JH Lee, J Han, Z Wang, SM Riester, L Jin, J Chen, ... Science 352 (6291), 1344-1348, 2016 | 243 | 2016 |
Both TEL and AML-1 contribute repression domains to the t (12; 21) fusion protein R Fenrick, JM Amann, B Lutterbach, L Wang, JJ Westendorf, JR Downing, ... Molecular and cellular biology, 1999 | 204 | 1999 |